Revenue from operations reported a marginal increase to ₹760 crore from ₹751 crore in the June 2024 quarter. Profit before depreciation, interest, and taxes (EBITDA) for the quarter was ₹14 crore, compared with a loss of ₹29 crore in the corresponding quarter of the previous year, according to a statement.
On a consolidated basis, the company’s profit after tax stood at ₹464 crore, as against ₹226 crore in the year-ago period. Earnings before interest, tax, depreciation, and amortisation (EBITDA) was ₹895 crore, compared with ₹528 crore a year ago, recording an increase of 70 per cent. Consolidated revenue from operations rose by 29 per cent to ₹8,724 crore, as against ₹6,747 crore.
The revenues of the sugar segment for the current quarter stood at ₹347 crore, compared with ₹404 crore in the corresponding quarter of the previous year, registering a de-growth of 14 per cent due to a lower release quota.
“The sugar segment registered a loss of ₹49 crore, as compared to a loss of ₹59 crore in the corresponding quarter of the previous year, on account of higher cane volume (2.11 lakh tonnes in Q1 FY25 vs. 1.93 lakh tonnes in Q1 FY24), better realization, and cost optimisation. This was partly offset by lower recoveries and higher cane cost,” said Muthiah Murugappan, Whole-time Director and Chief Executive Officer of the company.
The distillery segment reported revenues of ₹296 crore for the current quarter, reflecting a 12 per cent increase from ₹263 crore in the corresponding quarter of the previous year. This growth was driven by improved capacity utilization following the completion of expansion projects. Segment profit rose to ₹20 crore, up from ₹13 crore in the same quarter last year, supported by higher sales volumes and effective cost optimization measures.
The Consumer Products Group recorded a turnover of ₹192 crore for the quarter, marking an 11 per cent decline from ₹216 crore in the same period last year. The drop was primarily due to a lower release quota in the sweetener category. However, this was partially offset by a strong performance in the staples segment, which registered a 33 per cent year-on-year growth.
The nutraceuticals segment posted revenues of ₹5.94 crore for the current quarter, down 29 per cent from ₹8.41 crore in the corresponding quarter of the previous year. The segment reported a reduced loss of ₹0.20 crore, compared to ₹0.26 crore in the same period last year, aided by cost optimization despite lower revenue.
